Gland Pharma Enters Into An Agreement To Manufacture 252 Million Doses Of Sputnik V
Hyderabad-based Gland Pharma has entered into an agreement with Russian sovereign wealth fund, Russian Direct Investment Fund (RDIF), to manufacture and supply 252 million (25.2 crore) doses of Russian Covid-19…
Share